BiomarkersHumans
BLOOD-BASED BIOMARKERS FOR ALZHEIMER’S DISEASE AND NEURODEGENERATION IN RELATION TO INCIDENT COGNITIVE STATUS
GSA 2024 Abstract
Abstract
Blood-based biomarkers for Alzheimer’s Disease (AD) and neurodegeneration, including amyloid-beta (AB), ptau-181, glial fibrillary acidic protein (GFAP), and neurofilament light (NFL), could advance the monitoring and detection of individuals at high risk for adverse cognitive outcomes.
The paper
University of Mississippi Medical Center · University of North Carolina at Chapel Hill
GSA 2024 Abstract · 31 Dec 2024 · CC BY
Presented at GSA 2024
